Palo Alto, CA, United States of America

Manley Huang

USPTO Granted Patents = 5 

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 144(Granted Patents)


Company Filing History:


Years Active: 2004-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Manley Huang: Innovator in Cancer Treatment

Introduction

Manley Huang is a prominent inventor based in Palo Alto, California. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of five patents to his name, Huang's work focuses on enhancing anti-tumor immunity and developing novel therapeutic methods.

Latest Patents

Huang's latest patents include groundbreaking inventions such as "Methods and compositions for vaccinating and boosting cancer patients." This invention provides methods for inducing and expanding anti-tumor immunity, leading to enhanced clinical and immunotherapeutic responses. Additionally, it offers novel compositions and methods for the treatment of cancer. Another notable patent is "Polyclonal bispecific antibody compositions and method of use." This invention relates to compositions and methods for treating a host infected with a pathogen, comprising a population of polyclonal bispecific binding molecules that can target and eliminate a host cell infected with the pathogen. It also includes methods for activating and arming cytotoxic immune cells for treating patients infected with a pathogen.

Career Highlights

Throughout his career, Manley Huang has worked with various organizations, including Transtarget, Inc. and Wayne State University. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research in cancer treatment.

Collaborations

Some of Huang's notable coworkers include Lawrence G. Lum and Victoria Knepp Maskiewicz. Their collaborative efforts have contributed to the advancement of innovative solutions in cancer therapy.

Conclusion

Manley Huang's contributions to cancer treatment through his patents and collaborations highlight his dedication to improving patient outcomes. His innovative approaches continue to pave the way for advancements in immunotherapy and cancer care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…